Riposte des entreprises au VIH/SIDA : impact et leçons tirées.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|---|
![]() |
WHO HQ READING-RM | DC-HQ | WC 503.7 2000BU-1 (Browse shelf(Opens below)) | 1 | Available | 00080200 |
Browsing WHO HQ shelves, Shelving location: READING-RM, Collection: DC-HQ Close shelf browser (Hides shelf browser)
No cover image available | ||||||||
WC 503.7 2000BA Guidelines for studies of the social and economic impact of HIV/AIDS / | WC 503.7 2000BA-1 Principes directeurs applicables aux études de l' impact social et économique du VIH/SIDA / | WC 503.7 2000BU The Business response to HIV/AIDS : | WC 503.7 2000BU-1 Riposte des entreprises au VIH/SIDA : | WC 503.7 2000ET Ethical considerations in HIV preventive vaccine research. | WC 503.7 2000ET-1 Cuestiones éticas en la investigación de vacunas preventivas contra el VIH. | WC 503.7 2001PA Paying for HIV/AIDS services : |
Produced by the Joint United Nations Programme on HIV/AIDS, the Prince of Wales Business Leaders Forum and the Global Business Council on HIV & AIDS.
eng fre.
WHODOC
WHO monograph
ONUSIDA/02.03F
4
There are no comments on this title.